MRMD - MariMed Inc.
| Previous Close | 4.0000 |
| Open | 3.9700 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 3.8700 - 4.2000 |
| 52 Week Range | 0.6900 - 5.8000 |
| Volume | 508,108 |
| Avg. Volume | 496,191 |
| Market Cap | 844.719M |
| Beta (3Y Monthly) | 3.49 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.11 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE•yesterday
4 Marijuana Stocks Making New Highs on Latest Headlines
CORAL GABLES, FL / ACCESSWIRE / January 18, 2019 / Marijuana stocks have become one of the hottest topics in the news over the course of the past week years, but the last few weeks have remained especially positive for the industry. With the introduction of the US Farm Bill and the advent of legal hemp, cannabis stocks have seen impressive gains over the last month or so, with no signs of slowing down. Premier Health Group (OTC:PHGRF) (CSE:PHGI) has seen impressive growth throughout the last few weeks of January, as the cannabis sector has garnered significant notoriety, as well as a major increase in public support.
- GlobeNewswire•4 days ago
MariMed Forms MariMed Hemp, Inc. Subsidiary For Hemp-Derived CBD Product Branding and Distribution
MariMed Inc. (MRMD), a leading multi-state cannabis operator, today announced the formation of MariMed Hemp, Inc., a wholly-owned subsidiary to be entirely focused on hemp-derived CBD products. MariMed Hemp will have a dedicated executive team, proprietary brand and product lines, and distribution and marketing relationships, all separate from MariMed’s core cannabis business. The subsidiary builds on MariMed’s recent investment in GenCanna Global, a leader in high-quality, fully compliant hemp cultivation and processing which is acclaimed for its genetics, proprietary cultivation practices and best in class processing procedures that produce world class, GMP, quality CBD isolates and oils.
- Motley Fool•6 days ago
These 3 Stocks Trounced the Top Marijuana ETFs in 2018, and Here's Why They'll Do It Again This Year
Repeat performances could be in store for these big marijuana winners from last year.
- PR Newswire•8 days ago
The Canadian Securities Exchange (CSE), Kapoor Kapital, and OTC Markets Group to Co-Host Canada Cannabis House in Davos, Switzerland
NEW YORK and TORONTO , Jan. 11, 2019 /PRNewswire/ -- The Canadian Securities Exchange (CSE), a Canadian listing exchange recognized as a Qualified Foreign Exchange in the U.S., Kapoor Kapital, and OTC ...
- GlobeNewswire•9 days ago
MariMed to be Featured at Benzinga Cannabis Capital Conference Jan 16th
Norwood, MA and MIAMI, Jan. 10, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD) CEO Robert Fireman will be a featured presenter at the second annual Cannabis Capital Conference, hosted by premier financial media outlet Benzinga, to be held in Miami, Florida, Jan. 15-16, 2019. Fireman’s MariMed presentation will be at 1:50 pm in Ballroom 3 at Eden Roc Hotel-Miami Beach, 4525 Collins Avenue, Miami Beach, Fla. Mr. Fireman, who grew MariMed from its early stages to a multi-state, publicly traded cannabis organization that was one of the top performing cannabis stocks of 2018, will be in good company with presenters including top investors like CNBC's Tim Seymour, Jon Najarian and New Cannabis Ventures founder Alan Brochstein and other top cannabis company CEOs.
- Motley Fool•10 days ago
Why Marijuana Stock MariMed Soared 371% in 2018
This cannabis stock was on fire last year. Here's what investors should know.
- Benzinga•10 days ago
'Long Overdue': Experts React To The Passage Of The Farm Bill, Hemp Legalization
From companies going public on major exchanges, mergers and acquisitions and full legalization of weed in Canada, 2018 was a transformational year in cannabis. One major milestone for the industry was the passage of the 2018 Farm Bill. The legalization of hemp and its removal from Schedule I of the Controlled Substances Act is viewed as a major step forward for the cannabis industry because it legalizes hemp-derived cannabidiol, or CBD.
Bloomberg•11 days agoAs New Jersey Marijuana Debate Drags On, New York Enters East Coast Race
Legalization, which New Jersey Governor Phil Murphy wanted in 2018, has been mired in debates over taxation and how to erase existing marijuana-related convictions. Pressure to get a deal done has grown in recent weeks as the governors of New York and Pennsylvania called for legal pot, threatening New Jersey’s bid to be the first New York City-area state to offer sales. “We would be the economic engine for the state -- there’s no question -- but right now it’s not something I could support,” said Steve Fulop, Jersey City’s mayor and a former Wall Street trader.
- Motley Fool•15 days ago
Better Buy: Medical Marijuana, Inc. vs. MariMed Inc.
Which of these penny cannabis stocks is the better buy right now?
- ACCESSWIRE•19 days ago
These 4 Healthcare Stocks May Test December Highs
CORAL GABLES, FL / ACCESSWIRE / December 31,2018 / This year has been a year which has seen significant market volatility, but the healthcare sector has managed to remain above the curve by constantly working to design and implement innovative approaches to medical care for patients suffering from a variety of serious illnesses. As experts and professionals in the field have worked on developing technologies to improvequality of care available for consumers, the healthcare industry, as a whole, has seen tremendous growth. Premier Health Group (PHGRF) (PHGI), Axsome Therapeutics Inc (AXSM), Marimed Inc (MRMD), and Marker Therapeutics Inc (MRKR) are 4 healthcare companies worth keeping tabs on as we head into the new year.
- ACCESSWIRE•24 days ago
These 4 Marijuana Stocks Are Raising Eyebrows
CORAL GABLES, FL/ ACCESSWIRE / December 26, 2018 / While all other sectors of the market are concerned with high volatility, the cannabis industry has enjoyed positive gains as a result of recent legislation passed that will allow producers to ramp up production to meet the needs of consumers in the space. Premier Health Group (PHGRF) (PHGI), MariMed Inc (MRMD), New Age Beverages Corp (NBEV), and CV Sciences, Inc (CVSI) are 4 pot stocks to pay attention to as we approach the new year. Premier Health Group (PHGRF) (PHGI) saw its company shares enjoy a 2.87% boost in midday trading on Wednesday afternoon, trading at $0.64 per share, up from $0.53 at the end of October and $0.59 on December 9.
- GlobeNewswire•last month
MariMed Primed to Meet Soaring Demand as Hemp CBD Era Begins
The Hemp CBD Era officially begins with the 2018 Farm Bill signed into law today by President Trump, according to MariMed, Inc. The landmark legislation, which legalizes industrial hemp, opens doors for MariMed, GenCanna Global (GenCanna) and other US businesses to meet soaring demand for Hemp CBD that analysts expect to grow from today’s $800 million to $22 billion by 2022. For the past few years, demand for CBD has far outpaced supply, as consumers discovered CBD’s efficacy for treating a range of medical conditions, including pediatric epilepsy, some cancers (and painful cancer treatments), acute anxiety, arthritic and chronic pain, high blood pressure, and various skin conditions, including acne.
- Motley Fool•last month
4 Under-the-Radar Marijuana Stocks That Benefit if New Jersey Legalizes Recreational Pot
New Jersey's cannabis market could be worth $850 million by 2022.
- ACCESSWIRE•last month
Medical Marijuana Stocks Take Center Stage Amid Farm Bill Excitement
CORAL GABLES, FL / ACCESSWIRE / December 17, 2018 / Since California first passed a proposition legalizing marijuana for medical purposes more than 20 years ago, medical marijuana has seen a rise in state and public support. Marijuana stocks have recently gotten more attention as industry growth continues to prosper. Cannabis has been approved for medical use in 33 states, as of November 2018, and is used to treat symptoms associated with diseases such as AIDS, cancer, and glaucoma.
- Market Exclusive•last month
Marimed Expects To Lead In Hemp Derived CBD Following 2018 Farm Bill Passage
As the United States waits for president Trump to sign the 2018 Farm Bill before next year, cannabis operator Marimed Inc (OTCMKTS:MRMD) has made an official announcement concerning a significant investment in hemp. The statement has hailed the passing of the Bill and its becoming law soon as this is considered the official inauguration of […] The post Marimed Expects To Lead In Hemp Derived CBD Following 2018 Farm Bill Passage appeared first on Market Exclusive.
- Motley Fool•last month
Hemp Is on the Verge of U.S. Legalization: Could MariMed Profit?
Marijuana stock investors: The market for hemp-derived CBD products is expected to balloon to $22 billion by 2022.
- ACCESSWIRE•last month
Marijuana Stocks to Watch & What to Expect from the 2018 US Farm Bill
CORAL GABLES, FL / ACCESSWIRE / December 14, 2018 / The United States Senate and House passed the 2018 Farm Bill this week thus paving the way for CBD and hemp legalization. Hemp products are made in America, sold in America, and consumed in America.
- GlobeNewswire•last month
MariMed Positioned to be Leader in Hemp CBD Era with 2018 Farm Bill Signing Imminent
As President Trump prepares to sign the 2018 Farm Bill into law in coming days, MariMed, Inc. “The expected signing of the Farm Bill will enable Americans to enjoy legal access to a host of hemp-derived CBD-based solutions, which are already renowned for their health and wellness benefits, ,” said Robert Fireman, MariMed CEO. “MariMed expects to make a series of Hemp CBD product and distribution announcements in 2019.
- Market Exclusive•last month
Demand For Cannabis Prompts Marimed To Expand CBD Hemp Operations
The cannabis industry is quickly turning into a multi-billion dollar powerhouse thanks to the drastic demand for cannabis products. Reports have it that cannabis revenues are likely to hit $9 billion by the end of the year. This kind of speculation has resulted in serious investment by various companies seeking to grab a share of […] The post Demand For Cannabis Prompts Marimed To Expand CBD Hemp Operations appeared first on Market Exclusive.
- ACCESSWIRE•last month
MariMed Is Expanding Cannabis and CBD Hemp Operations, New Capital Infusion
NEW YORK, NY / ACCESSWIRE / December 10, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...
- Motley Fool•2 months ago
Better Marijuana Stock: MariMed vs. MedMen
Which of these two U.S. marijuana stocks is poised to be the bigger winner?
- Benzinga•2 months ago
Medical Marijuana Is Making Big Money In Maryland
When medical cannabis became legal in Maryland last year, New Frontier Data projected 2018 sales would come in at around $46 million. When compared to other states with high median incomes, such as Hawaii, California and Massachusetts, Maryland remains a fairly inexpensive state in which to live. Marijuana is still only medically legal in Maryland, and it’s already on pace to bring in $1 million in its first year.
- PR Newswire•2 months ago
Cannabis Sector Leaders Leveraging Expertise and Real Estate as Possible Federal Legalization Looms
The pendulum of cannabis legalization in the US seems to have begun to swing back towards a positive stance over the first half of 2018. With the rise of cannabis legalization across North America, has come with it a rise in the prevalence of niche expertise in the sector.
- Benzinga•2 months ago
As Congress Bickers Over Farm Bill, MariMed Gets Internationally Busy Down Under
As the industry impatiently awaits passage of the 2018 Farm Bill and pending removal of hemp from the Controlled Substances Act, companies are quickly moving to position themselves as leading suppliers of hemp-based CBD products, and investors are all too happy to help foot the bill. Two companies that have been particularly aggressive in their pursuit of the hemp-based CBD market have been Elixinol Global Ltd. (OTCQX: ELLXF) and MariMed, Inc. (OTCQB:MRMD). Shares for the IPO were sold at $1.00 AUD per share ($0.73 USD), but the stock quickly climbed to $1.82 AUD ($1.32 USD) within the first week of trading.
